Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
Previous close
$319.12
−$0.89 · -0.28%
Regular session · ET · Market data may be delayed.
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
Day range
Current $319.12
52-week range
Current $319.12
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
33
Expensive
Sentiment
47
Mixed
Risk
14
Low Risk
Momentum
42
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
Day range
Current $319.12
52-week range
Current $319.12
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.4B USD | 1.19B USD | 1.06B USD | 847.13M USD | 747.59M USD |
| Cost of goods sold | 461.23M USD | 439.62M USD | 375.88M USD | 311.93M USD | 272.21M USD |
| Gross profit | 942.44M USD | 755M USD | 682.64M USD | 535.21M USD | 475.38M USD |
| Research and development | 89.77M USD | 94.78M USD | 84.42M USD | 79.41M USD | 104.55M USD |
| Selling, general, and administrative | 663.42M USD | 573.99M USD | 506.45M USD | 449.72M USD | 378.33M USD |
| Operating expenses | 753.19M USD | 668.77M USD | 609.09M USD | 529.13M USD | 482.88M USD |
| Interest income | 16.29M USD | 13.69M USD | 6.83M USD | 1.89M USD | 2.87M USD |
| Interest expense | 1.31M USD | 1.42M USD | 1.74M USD | 1.75M USD | 1.93M USD |
| Depreciation and amortization | 17.47M USD | 23.7M USD | 27.26M USD | 24.32M USD | 16.41M USD |
| Operating income | 189.25M USD | 86.22M USD | 73.55M USD | 6.08M USD | −7.5M USD |
| Net income | 177.69M USD | 14.01M USD | 90.95M USD | −2M USD | 5.28M USD |
Company facts updated Nov 22, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$320
0.28% upside| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Nov 16, 2014 | 1:10 | — | — |
Effective Nov 16, 2014
1:10
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Mid-Cap ETFIJH452.91M0.39%115.06B USD0.05%$68.60-2.68%
Vanguard Morningstar Total Stock Market ETFVTI299.06M0.02%689.3B USD0.03%$340.02-3.52%
Vanguard Morningstar Small-Cap ETFVB267.59M0.15%78.7B USD0.03%$270.68-2.56%
Vanguard Morningstar Small-Cap Growth ETFVBK149.76M0.35%22.5B USD0.05%$298.35-3.85%
Vanguard Extended Market ETFVXF142.17M0.15%30.2B USD0.05%$211.44-3.21%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY94.37M0.38%24.52B USD0.23%$626.03-2.64%
iShares S&P Mid-Cap 400 Growth ETFIJK77.57M0.81%9.6B USD0.16%$99.99-3.36%
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMD69.36M0.38%18.06B USD0.03%$60.11-2.66%
iShares Core S&P Mid-Cap ETFIJH
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Morningstar Small-Cap ETFVB
Vanguard Morningstar Small-Cap Growth ETFVBK
Vanguard Extended Market ETFVXF
State Street SPDR S&P MIDCAP 400 ETF TrustMDY
iShares S&P Mid-Cap 400 Growth ETFIJK
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMDAI-generated and delayed market data for informational and educational purposes only. Not investment advice.